12/08/2015 - 22:39

Analytica appoints medical heavyweight to board

12/08/2015 - 22:39


Save articles for future reference.

Former European Medicines Agency Executive Director takes up role at ASX listed medical technology company

Analytica appoints medical heavyweight to board
"PeriCoach" incontinence device

Listed Australian medical device company Analytica has significantly raised its profile with the appointment of international medical device expert Dr Thomas Lönngren to its board.

Dr Lonngren is the former Executive Director of the European Medicines Agency and he also served as the Deputy Director General of the Medical Products Agency in Sweden.

Dr Lönngren's current positions include Director and Founder of Pharma Executive Consulting Ltd in London, Strategic Advisor at NDA Group in Sweden, Germany, UK and Cambridge and Non-Executive Director of Global Kinetics Corporation in Australia.

He also holds a Degree in Pharmacy and a Master of Science Degree in social and regulatory pharmacy from the University of Uppsala.

Dr Lonngren holds an Honorary Doctorate from the University of Bath, UK (2011), an Honorary Doctorate from the University of Uppsala, Sweden (2008), an Honorary Fellow of the Royal College of Physicians and Honorary Member of the Royal Pharmaceutical Society of Great Britain.

Analytica has recently commercialized its “PeriCoach” medical device that monitors a woman’s pelvic floor muscles whilst they are being exercised in order to reduce and eventually eliminate incontinence.

The PeriCoach device sends a wireless signal to a smart phone for the purposes of confirming that pelvic floor muscles are being correctly exercised in accordance with medical instructions.

According to the company 1 in 3 women worldwide suffer from incontinence and many fail to perform pelvic floor remedial exercises correctly. 


Subscription Options